Indications
Treatment of Wilson's disease.
Composition
- Active substance
- zinc
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Wilzin
- Active substance
- zinc
- ATC code
- A16AX05
- Therapeutic area
- Hepatolenticular Degeneration
- Marketing authorisation holder
- Recordati Rare Diseases
- Status
- Authorised
- EU authorisation
- 12 Oct 2004
- EMA product number
- EMEA/H/C/000535